picotamide has been researched along with Kidney Failure, Chronic in 1 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vandelli, L | 1 |
| Grosoli, M | 1 |
| Lusvarghi, E | 1 |
| Cenci, AM | 1 |
| Campioli, D | 1 |
| Grossi, G | 1 |
1 other study available for picotamide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
Topics: Aged; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phthalic Acids; Platelet Aggregati | 1989 |